33. Comparison of bone morphogenetic protein and allogeneic stem cells in lateral interbody lumbar fusion

Lateral interbody fusion (LLIF) is often performed with biologic adjuvants to promote fusion. Commercially available bone allograft containing allogeneic stem cells (ASC) and bone morphogenetic protein-2 (BMP) are designed to promote fusion while avoiding the morbidity of iliac crest autograft; however, no study to date has directly compared the two in LLIF. The ASC studied is Osteocel Pro (NuVasive, Inc).

Source: The Spine Journal - August 23, 2019 Category: Orthopaedics Authors: Elizabeth L. Lord, Jordan H. Manning, Erik Wang, Dennis Vasquez-Montes, Deeptee Jain, Themistocles S. Protopsaltis, Charla R. Fischer, Aaron J. Buckland, Jeffrey A. Goldstein, Peter G. Passias, Yong H. Kim, John A. Bendo Source Type: research